https://www.selleckchem.com/pr....oducts/chir-99021-ct
Chronic inflammation is a risk factor for cardiovascular disease (CVD). IL-6 signalling perturbation through IL-6 or IL-6R blockade may have potential benefit on cardiovascular risk. It is unknown whether targeting either IL-6 or IL-6 receptor may result in similar effects on CVD and adverse events. We compared the anticipated effects of targeting IL-6 and IL-6 receptor on cardiometabolic risk and potential side effects. We constructed four instruments two main instruments with genetic variants in the IL6 and IL6R loci we
Like
Comment
Share
